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To the Editor: In July 2010, 
dengue virus serotype 4 (DENV-
4) reemerged in Boa Vista, the 
capital of Roraima State, in northern 
Brazil (Figure, panel A), after an 
absence of 28 years (1). Cases were 
identifi ed during late June in the 
municipalities of Boa Vista and Cantá. 
For all patients, the clinical course of 
disease was classic, and all recovered 
uneventfully. The most commonly 
reported signs and symptoms were 
fever, headache, chills, muscle and 
joint pains, rash, nausea and vomiting, 
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Figure. A) Boa Vista, Roraima State, Brazil, showing the districts where dengue virus 
type 4 (DENV-4) was isolated. 1, Liberdade; 2, Buritis; 3, Cauamé; 4, Santa Tereza; 5, 
Cidade Satélite; 6, Dr. Silvio Leite; 7, Joquel Clube; 8, Sen. Hélio Campos. B) Phylogenetic 
analysis of the DENV-4 envelope gene sequences (in boldface) constructed by using the 
neighbor-joining method, showing the cluster formed by Boa Vista and Venenzuela DENV-
4 genotype I strains. Bootstrap values were set for 1,000 replicates and are placed over 
each main node of the tree. ROR1982 represents the DENV-4 isolated in Roraima State 
during the 1982 epidemic. A to B1–B4 represent genotype I subclades. Thailand 1978 
and Thailand 1985 strains represent the Asian genotype II. Scale bar corresponds to 1% 
nucleotide sequence divergence.
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and retro-ocular pain. Patient ages 
were 11–51 years (median 31 years); 
5 patients were male.
Because of the clinical picture, 
dengue was suspected, and serum 
samples were collected and sent 
to Instituto Evandro Chagas for 
virus isolation. Of 10 DENV strains 
recovered, 9 were isolated into C6/36 
cell samples as described elsewhere 
(2). Cytopathic effects were observed 
on days 5–7 postinfection, and virus 
isolation was confi rmed by use of 
indirect immunofl uorescent assay (3). 
Molecular approaches led to diagnosis 
of 10 cases. Viral RNA was recovered 
from infected cells in the supernatant 
by using a QIAquick viral RNA 
extraction kit (QIAGEN, Valencia, 
CA, USA); genome amplifi cation 
was performed by using a 1-step 
reverse transcription–PCR (RT-PCR) 
(4) and 2 set of oligonucleotides 
designed to amplify the entire N gene 
in overlapping PCR products. PCR 
amplifi cation was performed on 5 
DENV strains, and the envelope gene 
(1,425 bp) was completely sequenced 
by the dideoxinucleotide terminator 
method for 3 strains (5) by using the 
same set of oligonucleotides as for the 
RT-PCR amplifi cation.
Phylogenetic analysis was 
performed by using the neighbor-joining 
method (6) and homologous sequences 
of different DENV-4 strains isolated in 
Central and South America (7,8). The 
Asian genotype II strains (Thailand 
1978-U18441 and Thailand 1985-
AY780644) were used as outgroups 
to give confi dence to phylogenetic 
groupings. Phylogenetically, the 
DENV-4 strains grouped in genotype 
I and clustered with Venezuelan strains 
isolated from 2004 through 2007 
(Brazil/Venezuela group) and were 
distantly related to strains isolated in 
Venezuela from 1998 through 2000. 
This result indicates that the current 
DENV-4 strains isolated in Roraima 
State were reintroduced to Brazil 
through Venezuela, where DENV-4 
has circulated since the 1980s (1). This 
result also excludes the possibility that 
Asian genotypes previously circulated 
in Brazil. The DENV-4 strains isolated 
from patients in Roraima State in 2010 
were genetically distinct from DENV-
4 strains isolated in the 1980s (Figure, 
panel B). 
During the 2010 outbreak, 
cocirculation of DENV-1 and 
DENV-2 in addition to DENV-4 was 
demonstrated by virus isolation (68 
strains) and RT-PCR amplifi cation 
(genome detection in 39 strains). The 
municipality of Boa Vista, which has 
≈266,901 inhabitants, reported 5,243 
dengue cases (3,936 dengue fever, 259 
severe dengue or dengue hemorrhagic 
fever) in 2010 (epidemiologic week 
37), many of them diagnosed by 
serologic testing (9). These numbers 
represent an increase of 154% over 
the 2,066 cases reported in 2009 (10).
DENV-4 had been introduced to 
Brazil through Boa Vista before the 
reemergence reported here; in 1982, 
DENV-1 and DENV-4 were described 
in Brazil, and a serologic survey 
estimated 11,000 dengue infections 
(1). After that outbreak, DENV-4 was 
eradicated and not again detected until 
the episode reported here. To monitor 
the circulation of DENV-4 in Roraima 
and other Brazilian states through 
the present date (epidemiologic week 
48), strong serologic and virologic 
surveillance have been conducted; 
cases of this serotype have not been 
recognized outside Roraima State. As a 
preventive measure in Boa Vista, a total 
of 10,358 dwellings were visited and 
18,305 larval Aedes aegypti mosquito 
foci were eliminated by spraying of 
mosquito adulticide. Nonetheless, as 
summer approaches in Brazil, a heavy 
rainy season is expected, and DENV-
4 is a candidate to become a serious 
threat in the country. Therefore, the 
Ministry of Health has prepared a plan 
to investigate DENV-4 circulation; it 
calls for early detection of disease and 
adoption of control measures to avoid 
or minimize spread of this dengue 
serotype throughout the country.
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To the Editor: Phleboviruses 
(family Bunyaviridae, genus 
Phlebovirus) are arthropod-borne, 
single-stranded, RNA viruses. Their 
genome consists of 3 segments—small, 
medium, and large—which encode 
the nucleoprotein and nonstructural 
proteins, the envelope glycoproteins, 
and the viral polymerase, respectively 
(1). The genus Phlebovirus consists 
at least 60 antigenically distinct 
serotypes, including the sandfl y 
fever viruses transmitted to humans 
by phlebotomine sandfl ies. In the 
Mediterranean region, 3 phleboviruses 
are known to circulate: Toscana virus, 
sandfl y fever Naples virus, and sandfl y 
fever Sicilian virus. Sandfl y fever 
Naples virus and sandfl y fever Sicilian 
virus cause a transient febrile illness, 
whereas Toscana virus is sometimes 
neurovirulent, leading to aseptic 
meningitis and meningoencephalitis 
(2,3).
Phleboviruses have been detected 
in Greece in clinically ill persons and 
in sandfl ies; seroprevalance in humans 
is high, especially in the Ionian 
islands (3–7). In addition, in 2002, 
a Sicilian-like virus (Cyprus virus) 
was responsible for a major outbreak 
of febrile illness among Greek Army 
forces in Cyprus (8). We report 
genetic detection and sequencing of 
an Adria virus from a boy who was 
hospitalized because of simple febrile 
seizure; the identical sequence was 
initially detected in sandfl ies collected 
in a coastal area in Albania.
On September 23, 2009, a 
2.5-year-old boy was admitted to the 
Hippokration Hospital of Thessaloniki, 
Greece, after a single episode of 
simple febrile seizure. The patient was 
febrile (38.2°C) and had vomited 1 
time while in nursery school. He had 
sudden onset of eye gaze, perioral 
cyanosis, masseter muscle spasm, 
generalized tonic convulsions of the 
body and extremities, and involuntary 
loss of urine. The episode lasted ≈3 
minutes, after which the child became 
irritable and sleepy.
At the time of hospital admission 
(30 minutes later), he was afebrile 
and conscious. The boy’s history 
contained no previous neurologic or 
developmental disabilities and no 
family history of epilepsy or febrile 
seizures. Clinical examination, 
which included a thorough general 
and detailed neurologic evaluation, 
revealed no abnormalities except 
mild rhinitis. Laboratory tests showed 
leukocytosis (22,600 cells/μL) with 
85.7% neutrophils. Blood levels of 
electrolytes, urea nitrogen, creatinine, 
glucose, albumin, bilirubin, alkaline 
phosphatase, and aminotransferases; 
prothrombin time; and urinalysis 
results were within reference limits. 
Electroencephalogram showed no 
brain abnormalities. Lumbar puncture 
and neuroimaging were not considered 
necessary.
After 2 days of hospitalization, 
the child recovered, was free of signs 
and symptoms, and was discharged 
from the hospital with a diagnosis of 
simple febrile seizure and mild upper 
respiratory infection. According to a 
report from his mother 1 year later, 
the child remains well without any 
recurrence of febrile or other type of 
seizures.
Viral RNA was extracted from 
the patient’s blood sample taken 
at the time of hospital admission. 
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Table. Percentage nucleotide and amino acid sequence divergence among phleboviruses*  
Virus















ADRV-GR 0 21.6 29.6 82.0 84.8 96.4
ADRV 0 21.6 29.6 82.0 84.8 96.4
SALV 3.0 3.0 33.5 83.6 89.8 100
ARBV 17.7 17.7 17.5 75.5 73.6 96.4
SFSV 85.6 85.6 85.6 82.3 76.1 70.7
TOSV 78.3 78.3 76.3 73.1 75.7 47.4
SFNV 86.7 86.7 86.2 87.0 84.1 29.2
*Values above the diagonal are nucleotide sequence divergence, and values below the diagonal are amino acid sequence divergence, estimated by 
neighbor-joining method. ADRV-GR, Adria virus from febrile child in Greece, 2009; ADRV, Adria virus;  SALV, Salehabad virus; ARBV, Arbia virus;  
SFSV, sandfly fever Sicilian virus;  TOSV, Toscana virus;  SFNV, sandfly fever Naples virus. 
